Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
clinical trials
fda
indiana blog main
indiana top stories
life sciences
6
×
national blog main
raleigh-durham blog main
raleigh-durham top stories
6
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
national
amgen
migraine research foundation
teva pharmaceutical
calcitonin gene-related peptide
cancer
chronic migraine
drugs
eptinezumab
erenumab
fremanezumab
What
drug
6
×
fda
6
×
approval
won
migraine
new
approved
class
companies
decades
developed
friday
oral
acute
addresses
agency
aimmune
allergy
amgen
arguments
awarded
big
bio
cancer
candidates
causes
commercialized
competitors
condition
digital
disease
drugs
eisai
eli
epidemic
fatty
flags
frenzied
gets
giant
Language
unset
Current search:
drug
×
biotech
×
" life sciences "
×
" raleigh-durham top stories "
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines